Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | W383G |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | CTNNB1 W383G lies within ARM repeat 6 of the Ctnnb1 protein (UniProt.org). W383G retains binding to E-cadherin and Tcf7l2, but results in a loss of binding to Apc in cultured cells, and leads to increased transcriptional activity in a reporter assay (PMID: 31857074), and therefore, is predicted to lead to a gain of Ctnnb1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 act mut CTNNB1 W383G |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41233406T>G |
cDNA | c.1147T>G |
Protein | p.W383G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_024453357.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001098209.2 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41233406T>G | c.1147T>G | p.W383G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|